Home
>
National Drug Code (NDC)
>
Dobutamine Hydrochloride
Dobutamine Hydrochloride - 52584-051-90 - (Dobutamine Hydrochloride)
Drug Information of Dobutamine Hydrochloride
| Product NDC: | 52584-051 |
| Proprietary Name: | Dobutamine Hydrochloride |
| Non Proprietary Name: | Dobutamine Hydrochloride |
| Active Ingredient(s): | 12.5 mg/mL & nbsp; Dobutamine Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dobutamine Hydrochloride
| Product NDC: | 52584-051 |
| Labeler Name: | General Injectables & Vaccines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074277 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100301 |
Package Information of Dobutamine Hydrochloride
| Package NDC: | 52584-051-90 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-051-90) > 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Dobutamine Hydrochloride
| NDC Code | 52584-051-90 |
| Proprietary Name | Dobutamine Hydrochloride |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-051-90) > 20 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 52584-051 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dobutamine Hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100301 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Strength Number | 12.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
